We are live on ! Find out more
ProShare Advisors

ProShare Advisors Portfolio holdings

AUM $67.5B
1-Year Est. Return 28.09%
This Fund
S&P 500
This Quarter Est. Return
-4.85%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$46.6B
AUM Growth
-$4.41B
Cap. Flow
-$915M
Cap. Flow %
-1.97%
Top 10 Hldgs %
31.78%
Holding
2,365
New
27
Increased
297
Reduced
1,868
Closed
169

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$170M
2
T icon
AT&T
T
+$142M
3
MSFT icon
Microsoft
MSFT
+$136M
4
XLNX
Xilinx Inc
XLNX
+$110M
5
AMZN icon
Amazon
AMZN
+$86.9M

Sector Composition

Rank Sector Weight
1 Technology 31.53%
2 Consumer Discretionary 13.24%
3 Communication Services 9.89%
4 Healthcare 9.39%
5 Consumer Staples 8.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MMI icon
1676
Marcus & Millichap
MMI
$1.15B
$280K ﹤0.01%
5,323
-648
-11% -$31K
PR
1677
Permian Resources
PR
$17.9B
$279K ﹤0.01%
34,550
-5,626
-14% -$44.4K
ZG icon
1678
Zillow
ZG
$7.02B
$279K ﹤0.01%
5,770
-323
-5% -$17.1K
EXAS
1679
DELISTED
Exact Sciences
EXAS
$278K ﹤0.01%
3,969
-358
-8% -$26.2K
PENG
1680
Penguin Solutions Inc
PENG
$2.76B
$278K ﹤0.01%
10,788
+1,678
+18% +$47.4K
ALEC icon
1681
Alector
ALEC
$164M
$277K ﹤0.01%
19,448
-4,759
-20% -$75.3K
AROC icon
1682
Archrock
AROC
$6.33B
$277K ﹤0.01%
29,973
-3,689
-11% -$31.6K
ELF icon
1683
e.l.f. Beauty
ELF
$4.56B
$277K ﹤0.01%
10,706
-1,322
-11% -$36K
SKIN icon
1684
SkinHealth Systems
SKIN
$94.9M
$276K ﹤0.01%
16,354
-2,464
-13% -$40.7K
RETA
1685
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$276K ﹤0.01%
8,407
-2,021
-19% -$60K
LBTYA icon
1686
Liberty Global Class A
LBTYA
$3.31B
$275K ﹤0.01%
10,776
-2,997
-22% -$79.4K
CDMO
1687
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$275K ﹤0.01%
13,471
-1,639
-11% -$33.4K
ACRS icon
1688
Aclaris Therapeutics
ACRS
$730M
$274K ﹤0.01%
15,905
-3,855
-20% -$52.6K
OPI
1689
DELISTED
Office Properties Income Trust
OPI
$274K ﹤0.01%
10,669
-1,307
-11% -$33.2K
DDS icon
1690
Dillards
DDS
$8.87B
$273K ﹤0.01%
1,016
-265
-21% -$68.4K
FROG icon
1691
JFrog
FROG
$9.71B
$272K ﹤0.01%
10,078
-1,480
-13% -$37.5K
RXRX icon
1692
Recursion Pharmaceuticals
RXRX
$1.57B
$272K ﹤0.01%
38,107
-9,542
-20% -$101K
AM icon
1693
Antero Midstream
AM
$10.8B
$271K ﹤0.01%
24,899
-4,408
-15% -$44.7K
BRKL
1694
DELISTED
Brookline Bancorp
BRKL
$271K ﹤0.01%
17,105
-2,104
-11% -$35.5K
DNOW icon
1695
DNOW Inc
DNOW
$2.63B
$271K ﹤0.01%
24,524
-3,028
-11% -$29.3K
NNI icon
1696
Nelnet
NNI
$4.79B
$271K ﹤0.01%
3,184
-526
-14% -$45.3K
ARRY icon
1697
Array Technologies
ARRY
$818M
$270K ﹤0.01%
23,952
-3,956
-14% -$44.4K
IOVA icon
1698
Iovance Biotherapeutics
IOVA
$2.23B
$270K ﹤0.01%
16,245
-5,851
-26% -$90.5K
VERV
1699
DELISTED
Verve Therapeutics
VERV
$270K ﹤0.01%
11,817
+1,595
+16% +$45.6K
RWT
1700
Redwood Trust
RWT
$616M
$269K ﹤0.01%
25,508
-3,183
-11% -$36.2K

Similar funds

ProShare Advisors's Q1 2022 Portfolio in Review

As of Q1 2022, ProShare Advisors held 2,365 positions worth $46.6B, down 8.6% from $51B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

ProShare Advisors's Q1 2022 filing shows 27 new, 297 increased, 1,868 reduced and 169 closed positions. Its largest new stake was Constellation Energy: 594,655 shares worth $33.4M. The largest sale was Apple, an estimated $170M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 33% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • ProShare Advisors's largest Q1 2022 buy was Constellation Energy: 594,655 shares worth $33.4M.
  • ProShare Advisors added most to Brown & Brown in Q1 2022, an estimated $161M increase.
  • ProShare Advisors's biggest Q1 2022 reduction was Apple, cutting an estimated $170M.
  • ProShare Advisors fully exited Xilinx Inc in Q1 2022, selling an estimated $110M.
  • ProShare Advisors's ten largest holdings make up 32% of its $46.6B portfolio in Q1 2022.
  • ProShare Advisors opened 27 new positions and closed 169 in Q1 2022.
  • ProShare Advisors's portfolio value fell 8.6% quarter-over-quarter to $46.6B.

Based on ProShare Advisors's 13F filing for Q1 2022, filed 10 May 2022.